|4Jan 26, 4:32 PM ET

Aggarwal Sumit 4

4 · Eloxx Pharmaceuticals, Inc. · Filed Jan 26, 2024

Insider Transaction Report

Form 4
Period: 2024-01-24
Transactions
  • Award

    Restricted Stock Units

    2024-01-24+60,00060,000 total
    Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

Documents

1 file
  • 4
    tm244260-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT